AI model developed by SOPHiA GENETICS and UroCCR predicts post-operative outcomes in kidney cancer study

SOPHiA GENETICS collaborated with the French Kidney Cancer Research Network (UroCCR) on a study using an AI algorithm to predict post-operative outcomes in renal cell carcinoma (RCC) patients, with results published in npj Precision Oncology. The study showed the AI model provided strong prediction compared to usual prognostic scores. UroCCR, a collaborative network focusing on kidney cancer, partnered with SOPHiA GENETICS to develop an AI-based model to predict cancer progression after surgery. The study demonstrated the benefits of using AI to analyze real-world data, highlighting the potential for AI to support clinical decision-making and personalized treatment for RCC patients.

Source link

error: Content is protected !!